amyotroph later sclerosis al fatal neurodegen disease character progress upper lower motor neuron defender one peculiar clinic characters wide distribute age onset probably caps differ combine entries oxygen factor investing whether modify convert common pathogen pathway lead either early late would imply identify phenotype biomass distinguish two popup patient elev consider therapeutic intervene toward aim different proteam analysis perform periphery blood mononuclear cell pmc group year match health control identify different express protein group gene ontology reveal signifies enrich cannot assoc protein fold response stress next valid select number belong function rematch use immunoassay result valid studi confirm decrease level peptidylprolyl mistral isomers also known cyclophilin heat shock sp alpha da glucoseregul bip deglycas dj similar obtain spinal cord soda mouse model suggest bail upregul involve proteostasi folds chaperone may base suspect put forward develop approach aim boost quality control system 